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Abstract
The molecular mechanism underlying muscarinic acetylcholine receptor-dependent LTD (mAChR-
LTD) in the hippocampus is less studied. In a recent study, a novel mechanism is described. The
induction of mAChR-LTD required the activation of protein tyrosine phosphatase (PTP), and the
expression was mediated by AMPA receptor endocytosis via interactions between GluA2, GRIP
and liprin-α. The hook-up of these proteins may result in the recruitment of leukocyte common
antigen-related receptor (LAR), a PTP that is known to be involved in AMPA receptor trafficking.
Interestingly, the similar molecular interaction cannot be applied to mGluR-LTD, despite the fact
that the same G-protein involved in LTD is activated by both mAChR and mGluR. This discovery
provides key molecular insights for cholinergic dependent cognitive function, and mAChR-LTD can
serve as a useful cellular model for studying the roles of cholinergic mechanism in learning and
memory.
Editorial
Activity-dependent changes in synaptic strength, such as
long-term potentiation (LTP) and long-term depression
(LTD), are thought to be the cellular models of learning and
memory [1]. In the hippocampus, several mechanistically
distinct forms of LTD have been reported. Two main forms
of LTD (NMDA receptor (NMDAR)- and metabotropic
glutamate receptor (mGluR)-dependent LTD), have been
intensively studied at hippocampal CA1 region and the sign-
aling pathways underlying LTD have been established. For
example, NMDAR-LTD can be induced by prolonged low
frequency stimulation (LFS). The mechanisms underlying
NMDAR-LTD include activation of NMDA receptor, postsy-
naptic Ca2+ elevation, and subsequent activation of protein
phosphatases. The AMPA receptor endocytosis is likely
important for the expression of the depression. mGluR-LTD
can be induced following paired-pulse LFS or DHPG (Group
I mGluR agonist) application, and is dependent on the acti-
vation of group I mGluR. Similar postsynaptic AMPA recep-
tor endocytosis and possible presynaptic reduction of
glutamate release are thought to contribute to reduced
responses [2-6].
Less attention has been paid to another form of LTD, one
which is dependent on muscarinic acetylcholine receptors
(mAChR). First described in the visual cortex, mAChR-LTD
was subsequently found in various brain regions, including
the perirhinal cortex and hippocampus [7-11]. Cholinergic
neurotransmission has been long implicated in memory and
cognition [12] and thus mAChR-LTD is proposed to be crit-
ical for cholinergic-related brain functions and disease. How-
ever, the molecular mechanisms underlying mAChR-LTD
remain largely unknown. Since mAChRs and mGluRs acti-
vate similar signaling pathways involving the same G-pro-
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teins and isoforms of phospholipase C (PLC) [13], it is
reasonable to expect that mAChR-LTD and mGluR-LTD
share similar molecular mechanisms. However, a recent
study by Dickinson and colleagues [this issue, Dickinson et
al., Molecular Brain] sheds new light on the molecular mech-
anisms underlying mAChR-LTD in the hippocampus. Using
whole-cell patch clamp recording in hippocampal CA1
pyramidal neurons from 4–5 week-old young rats, they
found that mAChR-LTD requires the activation of M1 recep-
tors and protein tyrosine phosphatases (PTPs), which in turn
result in AMPA receptor internalization via interactions
between GluA2, GRIP and liprin-α. However, these same
molecular interactions are not required for mGluR-LTD in
the hippocampus.
The major cholinergic innervations of the hippocampus
come from the medial septum [14]. Five different mus-
carinic receptor subtypes (M1-5) have been identified, all
of them are expressed in the hippocampus. Among them,
M1, 3, 5 are coupled to the Gq/11 and phospholipase C
(PLC) pathway, while M2 and 4 receptors negatively reg-
ulate adenylyl cyclases [15]. In the hippocampal CA1
region, mAChR-LTD has only recently been identified. It
is induced following application of the cholinergic mus-
carinic receptor agonist, carbachol (CCh) to hippocampal
slices [7,11]. Here Cho and colleagues demonstrate that
mAChR-LTD does not require the involvement of NMDA
receptors. Moreover, mAChR-LTD occurs independently
of mGluRs. These findings support the argument that
mAchR-LTD represents a unique form of LTD within the
hippocampus. Consistent with previous studies, M1
receptors were found to contribute to the induction of
mAChR-LTD. This is demonstrated by the use of a selec-
tive M1 receptor agonist 77-LH-28-1, and the antagonist,
pirenzepine. The cholinergic M1 receptor is known to link
to Gq and the subsequent PLC signaling pathway, which
induces Ca2+ release from intracellular Ca2+ store and acti-
vation of PKC. To further test whether mAChR-LTD is
Ca2+- or PKC-dependent, cyclopiazonic acid (for Ca2+
store depletion), BAPTA (Ca2+  chelator), Ro 32-0432
(PKC inhibitor) and PKC19-31 (inhibitory peptide for
PKC) were used and none was shown to affect mAChR-
LTD, providing the strong evidence that mAchR-LTD may
employ special signaling pathways. Postsynaptic applica-
tion of GDPβ S, a G-protein inhibitor, abolished mAChR-
LTD. Taken together, these results suggest that the induc-
tion of mAChR-LTD is dependent on M1 receptors and a
G-protein signaling mechanism, but not on a conven-
tional Gq-coupled pathway.
Protein phosphatases are known to contribute to hippoc-
ampal LTD [6]. For example, serine/threonine protein
phosphatases PP1 and PP2B are required for NMDAR-
LTD, while protein tyrosine phosphatase (PTP) is required
for mGluR-LTD [6,16,17]. Therefore, Dickinson and col-
leagues set out to study whether these phosphatases play
roles in mAChR-LTD. By postsynaptic application of
phosphatase inhibitors, they found that PTP, but not ser-
ine/threonine protein phosphatases, is required for
mAChR-LTD. In addition, they also found that protein
synthesis is not required for mAChR-LTD. This result is
quite surprising, since protein synthesis has been found to
be required for both mGluR-LTD and mAChR-LTD in
other studies [7,10,18]. It has been reported that extracel-
lular signal-regulated kinase (ERK) and mammalian target
of rapamycin (mTOR) translational activation pathways
contribute to protein synthesis-dependent LTD [7,19].
Because different results have been reported in term of the
requirement of protein synthesis in LTD, it would worth-
while in future studies to examine the roles of ERK and
mTOR pathways in mAChR-LTD.
How then is mAChR-LTD expressed? AMPA receptor
endocytosis is the key expression mechanism for both
NMDAR-LTD and mGluR-LTD [3,6,20,21]. In a previous
report, the surface GluA1 internalization has been
observed following CCh treatment in cultured hippocam-
pal neurons [7]. To examine the expression mechanism of
mAChR-LTD, Dickinson et al. compared the cell surface
and total expression level of GluA2 in control versus CCh-
treated hippocampal slices. Following CCh treatment
they observed a reduction in GluA2 expression on the cell
surface, while total expression levels of GluA2 remained
largely unchanged. These results suggest a significant
increase in GluA2-containing AMPA receptor endocytosis
following LTD induction.
A number of studies have revealed that AMPA receptor-
interacting proteins such as NSF, AP2, GRIP, ABP, and
PICK1 are critically involved in AMPA receptor trafficking
related synaptic plasticity [3,20,22]. Most notably, GRIP/
ABP and/or PICK1 are required for NMDAR-LTD in hip-
pocampus, cerebellum and cortex, while PICK1 is
required for mGluR-LTD in ventral tegmental area, cere-
bellum and perirhinal cortex [3,22]. However, it is still
unknown which interacting proteins are involved in
mAChR-LTD. To address this question, Dickinson et al.
used peptide inhibitors to block either the interaction
between GluA2 and PICK1 (pep2-EVKI), or between
GluA2 and GRIP/ABP as well as PICK1 (pep2-SVKI). They
found that pep2-SVKI, but not pep2-EVKI, inhibited
mAChR-LTD, suggesting that GRIP rather than PICK1 is
involved in mAChR-LTD. Interestingly, pep2-SVKI did not
block mGluR-LTD, which suggests that neither GRIP nor
PICK1 is involved. These findings indicate a different
mechanism is likely involved at the level of AMPA recep-
tor trafficking between mGluR- and mAChR-LTD.
To further examine the mechanisms by which GRIP mod-
ulates GluA2 trafficking and mAChR-LTD, they focused
on the GRIP interacting protein, Liprin-α, which can
directly interact with GRIP via its PDZ6 domain [23]. TheyMolecular Brain 2009, 2:17 http://www.molecularbrain.com/content/2/1/17
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found that disrupting the interaction between GRIP and
liprin-α using a synthetic peptide selectively blocked
mAChR-LTD but not mGluR-LTD and NMDAR-LTD.
These results suggest that the GRIP-liprin-α interaction is
specifically required for mAChR-LTD. Liprin-α could
recruit leukocyte common antigen-related receptors
(LAR), a PTP known to be involved in AMPA receptor traf-
ficking, axon guidance and neuronal development [24].
One attractive hypothesis is that activation of LAR phos-
phatase is triggered in mAChR-LTD via it's interaction
with the liprin-α-GRIP-GluA2 complex and the subse-
quent tyrosine dephosphorylation of GluA2. GluA2 tyro-
sine dephosphorylation results in the release of GluA2
from GRIP and AMPA receptor endocytosis, thereby
expressing LTD. Indeed, in the present study, spectrum
PTP inhibitors which can inhibit LAR phosphatase activity
are effective in blocking mAChR-LTD. In addition, it has
been reported that disruption of GRIP-liprin interactions,
or knockdown of LAR interfere with dendritic AMPA
receptor distribution [23,24].
In summary, Dickinson et al. examined the detailed
induction and expression mechanisms of mAChR-LTD in
hippocampal CA1 region. They nicely demonstrated that
cholinergic M1 receptors, G-protein signaling, PTP activity
and GluA2 internalization are involved in mAChR-LTD.
More importantly, their results reveal that the interaction
of GluA2-GRIP-liprin-α is required for mAChR-LTD, the
mechanisms of which may require the recruitment of LAR,
GluA2 tyrosine dephosphorylation, and thus AMPA
receptor endocytosis. The present study unveils a novel
cellular mechanism for mAChR-LTD, which is different
from mGluR-LTD. Future studies are needed to address
how the activation of M1 receptor leads to the recruitment
of LAR-liprin-α-GRIP-GluA2 pathway. In addition, gene
knockout mice deficient of AMPA receptor subunits can
be used to evaluate/confirm the roles of these subunits in
mAChR-LTD. Lastly, it would be valuable to identify
whether the mechanisms observed in the present study
are required for synaptically-induced mAChR-LTD in vivo
and the pathophysiological relevance of heterosynaptic
mAChR-LTD in brains under disease conditions.
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